Operated by Ieldas Inc. · Independent methodology · Affiliate-supported. Read our ownership & funding disclosure and how every figure is verified.
GLP1ProviderFinderUS price records
HomeCompare › MEDVi vs NovoCare Pharmacy (Wegovy)

Head-to-head · computed 2026-08-11

MEDVi vs NovoCare Pharmacy (Wegovy)

MEDVi: MEDVi advertises a $179 semaglutide start that tiers to $299 at maintenance; tirzepatide is $399 flat. NovoCare Pharmacy (Wegovy): Novo Nordisk's direct cash pharmacy sells FDA-approved Wegovy pens at $349/month across standard doses ($399 for the 7.2 mg HD pen), with a $199 introductory price on the first two starter-dose fills and oral Wegovy tablets from $149/month. It is the FDA-approved semaglutide price floor and the benchmark for every compounded semaglutide quote.

Tirzepatide

Only MEDVi offers tirzepatide ($399 a month billed monthly); NovoCare Pharmacy (Wegovy) does not, so there is no contest to score.

Semaglutide

MEDViNovoCare Pharmacy (Wegovy)
All-in maintenance$299/mo$349/mo
Best plan rate$299/mo$349/mo
12-month total$3,588$4,188
StatusProvider-stated · 2026-08-05Verified · 2026-08-11

The arithmetic

On the figures our desk holds, MEDVi's $299 a month undercuts NovoCare Pharmacy (Wegovy)'s $349 by $50 a month at the 2.4 mg/wk maintenance basis — $600 across a year. MEDVi's figure is provider-stated (captured 2026-08-05) and NovoCare Pharmacy (Wegovy)'s is verified (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.

MEDVi's semaglutide ladder runs $299 a month billed monthly. NovoCare Pharmacy (Wegovy)'s runs $349 a month billed monthly. On the twelve-month basis MEDVi's $3,588 beats NovoCare Pharmacy (Wegovy)'s $4,188 by $600 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.

Where the structures genuinely differ

On dose economics, MEDVi is dose-flat — the price survives titration — while NovoCare Pharmacy (Wegovy)'s pricing can move with the dose, a difference that compounds through a standard escalation schedule and matters most to buyers expecting to reach the higher maintenance doses.

Structure, side by side

MEDVi

  • MembershipNone
  • Dose policyTiered on semaglutide; tirzepatide flat
  • CommitmentMonth-to-month
  • CancellationCancel before renewal
  • PharmacyPartner pharmacies

NovoCare Pharmacy (Wegovy)

  • MembershipNone
  • Dose policyPen $349 (0.25–2.4 mg), Wegovy HD 7.2 mg $399; new-patient intro $199 for first two fills of 0.25/0.5 mg through Dec 31, 2026; oral Wegovy $149 (1.5 mg and 4 mg; 4 mg offer through Aug 31, 2026, then $199) up to ~$299 at higher tablet doses
  • CommitmentNone
  • CancellationNo subscription lock
  • PharmacyCoAssist Pharmacy d/b/a NovoCare Pharmacy

What our desk is watching on each

MEDVi: Start-vs-maintenance spread on semaglutide; compare on maintenance.

NovoCare Pharmacy (Wegovy): The $199 intro and the $149 oral tier both carry published expiration dates; the durable numbers are $349 pen / $399 HD.

Questions people ask

Is MEDVi or NovoCare Pharmacy (Wegovy) cheaper in 2026?

The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.

What does MEDVi vs NovoCare Pharmacy (Wegovy) miss that checkout will show?

Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.

Why do you compare at the maintenance dose instead of the starting dose?

Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.

What do MEDVi and NovoCare Pharmacy (Wegovy) cost over a full year of semaglutide?

On the plans our database holds, a year of semaglutide runs $3,588 at MEDVi and $4,188 at NovoCare Pharmacy (Wegovy) — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.

Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: MEDVi · NovoCare Pharmacy (Wegovy). Official sites: MEDVi ↗ · NovoCare Pharmacy (Wegovy) ↗. Nothing here is medical advice.